Developing novel agents targeting the NF-κB pathway for the treatment of multiple myeloma
The key aim was to characterise Nuclear factor-κB (NF-κB) inhibitors in four multiple myeloma (MM) cell lines to evaluate their use as potential therapeutic agents in this incurable haematological malignancy. The NF-κB inhibitors were characterised in terms of their effects on cytotoxicity, nuclear...
| Main Author: | |
|---|---|
| Published: |
Cardiff University
2017
|
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.738359 |